Segall Bryant & Hamill LLC Sells 539 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Segall Bryant & Hamill LLC decreased its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 0.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 301,670 shares of the company’s stock after selling 539 shares during the period. Segall Bryant & Hamill LLC’s holdings in Option Care Health were worth $9,442,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of OPCH. Avior Wealth Management LLC grew its stake in Option Care Health by 11.2% in the 3rd quarter. Avior Wealth Management LLC now owns 24,300 shares of the company’s stock valued at $761,000 after buying an additional 2,442 shares in the last quarter. Pathstone Holdings LLC boosted its holdings in shares of Option Care Health by 9.8% in the third quarter. Pathstone Holdings LLC now owns 68,895 shares of the company’s stock worth $2,156,000 after acquiring an additional 6,134 shares during the period. Lindenwold Advisors INC grew its position in shares of Option Care Health by 5.4% in the third quarter. Lindenwold Advisors INC now owns 9,548 shares of the company’s stock valued at $299,000 after purchasing an additional 489 shares in the last quarter. Thrivent Financial for Lutherans raised its stake in shares of Option Care Health by 7.4% during the 3rd quarter. Thrivent Financial for Lutherans now owns 5,863,930 shares of the company’s stock valued at $183,541,000 after purchasing an additional 404,811 shares during the period. Finally, Natixis Advisors LLC lifted its holdings in Option Care Health by 9.3% during the 3rd quarter. Natixis Advisors LLC now owns 88,751 shares of the company’s stock worth $2,778,000 after purchasing an additional 7,529 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Wall Street Analyst Weigh In

OPCH has been the subject of a number of recent analyst reports. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and reduced their target price for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Barrington Research decreased their target price on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Truist Financial reduced their price target on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Finally, Bank of America downgraded Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $43.00 to $29.00 in a research report on Wednesday, October 30th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $30.83.

Option Care Health Stock Performance

Option Care Health stock opened at $22.46 on Friday. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a market cap of $3.82 billion, a P/E ratio of 18.87, a price-to-earnings-growth ratio of 2.26 and a beta of 1.32. The firm’s fifty day moving average price is $27.80 and its 200-day moving average price is $29.16.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the transaction, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This represents a 15.18 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.64% of the stock is owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.